Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 167

1.

Treatment of candidemia in a nationwide setting: increased survival with primary echinocandin treatment.

Lausch KR, Søgaard M, Rosenvinge FS, Johansen HK, Boysen T, Røder BL, Mortensen KL, Nielsen L, Lemming L, Olesen B, Leitz C, Kristensen L, Dzajic E, Østergaard LJ, Schønheyder HC, Arendrup MC.

Infect Drug Resist. 2018 Nov 23;11:2449-2459. doi: 10.2147/IDR.S176384. eCollection 2018.

2.

Diagnostic accuracy of the 1,3-β-D-glucan test for pneumocystis pneumonia in a tertiary university hospital in Denmark: A retrospective study.

Engsbro AL, Najat S, Jørgensen KM, Kurtzhals JAL, Arendrup MC.

Med Mycol. 2018 Dec 11. doi: 10.1093/mmy/myy129. [Epub ahead of print]

PMID:
30535059
3.

Pediatric Candidemia Epidemiology and Morbidities: A Nationwide Cohort.

Lausch KR, Dungu KHS, Callesen MT, Schrøder H, Rosthøj S, Poulsen A, Østergaard L, Mortensen KL, Storgaard M, Schønheyder HC, Søgaard M, Arendrup MC.

Pediatr Infect Dis J. 2018 Sep 29. doi: 10.1097/INF.0000000000002207. [Epub ahead of print]

PMID:
30281546
4.

How to: EUCAST recommendations on the screening procedure E.Def 10.1 for the detection of azole resistance in Aspergillus fumigatus isolates using four-well azole-containing agar plates.

Guinea J, Verweij PE, Meletiadis J, Mouton JW, Barchiesi F, Arendrup MC; Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST).

Clin Microbiol Infect. 2018 Sep 28. pii: S1198-743X(18)30630-X. doi: 10.1016/j.cmi.2018.09.008. [Epub ahead of print] Review.

PMID:
30268672
5.

Implications of the EUCAST Trailing Phenomenon in Candida tropicalis for the In Vivo Susceptibility in Invertebrate and Murine Models.

Astvad KMT, Sanglard D, Delarze E, Hare RK, Arendrup MC.

Antimicrob Agents Chemother. 2018 Nov 26;62(12). pii: e01624-18. doi: 10.1128/AAC.01624-18. Print 2018 Dec.

PMID:
30224538
6.

High incidence of candidaemia in a nationwide cohort: Underlying diseases, risk factors and mortality.

Lausch KR, Søgaard M, Rosenvinge FS, Johansen HK, Boysen T, Røder B, Mortensen KL, Nielsen L, Lemming L, Olesen B, Leitz C, Kristensen L, Dzajic E, Østergaard L, Schønheyder HC, Arendrup MC.

Int J Infect Dis. 2018 Nov;76:58-63. doi: 10.1016/j.ijid.2018.08.010. Epub 2018 Aug 31.

7.

APX001A In Vitro Activity against Contemporary Blood Isolates and Candida auris Determined by the EUCAST Reference Method.

Arendrup MC, Chowdhary A, Astvad KMT, Jørgensen KM.

Antimicrob Agents Chemother. 2018 Sep 24;62(10). pii: e01225-18. doi: 10.1128/AAC.01225-18. Print 2018 Oct.

PMID:
30104264
8.

Isavuconazole in a Successful Combination Treatment of Disseminated Mucormycosis in a Child with Acute Lymphoblastic Leukaemia and Generalized Haemochromatosis: A Case Report and Review of the Literature.

Pomorska A, Malecka A, Jaworski R, Radon-Proskura J, Hare RK, Nielsen HV, Andersen LO, Jensen HE, Arendrup MC, Irga-Jaworska N.

Mycopathologia. 2018 Jul 23. doi: 10.1007/s11046-018-0287-0. [Epub ahead of print] Review.

PMID:
30039238
9.

Methodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms.

Van Dijck P, Sjollema J, Cammue BP, Lagrou K, Berman J, d'Enfert C, Andes DR, Arendrup MC, Brakhage AA, Calderone R, Cantón E, Coenye T, Cos P, Cowen LE, Edgerton M, Espinel-Ingroff A, Filler SG, Ghannoum M, Gow NAR, Haas H, Jabra-Rizk MA, Johnson EM, Lockhart SR, Lopez-Ribot JL, Maertens J, Munro CA, Nett JE, Nobile CJ, Pfaller MA, Ramage G, Sanglard D, Sanguinetti M, Spriet I, Verweij PE, Warris A, Wauters J, Yeaman MR, Zaat SAJ, Thevissen K.

Microb Cell. 2018 Jun 14;5(7):300-326. doi: 10.15698/mic2018.07.638. Review.

10.

Multicentre validation of 4-well azole agar plates as a screening method for detection of clinically relevant azole-resistant Aspergillus fumigatus.

Arendrup MC, Verweij PE, Mouton JW, Lagrou K, Meletiadis J.

J Antimicrob Chemother. 2018 Aug 1;73(8):2274. doi: 10.1093/jac/dky218. No abstract available.

PMID:
29800383
11.

EUCAST Determination of Olorofim (F901318) Susceptibility of Mold Species, Method Validation, and MICs.

Jørgensen KM, Astvad KMT, Hare RK, Arendrup MC.

Antimicrob Agents Chemother. 2018 Jul 27;62(8). pii: e00487-18. doi: 10.1128/AAC.00487-18. Print 2018 Aug.

PMID:
29784842
12.

[Diagnosing and treating of onychomycosis].

Tolstrup J, Jemec GB, Hare RK, Arendrup MC, Saunte DM.

Ugeskr Laeger. 2018 May 14;180(20). pii: V10170785. Danish.

PMID:
29761779
13.

Invasive candidiasis.

Pappas PG, Lionakis MS, Arendrup MC, Ostrosky-Zeichner L, Kullberg BJ.

Nat Rev Dis Primers. 2018 May 11;4:18026. doi: 10.1038/nrdp.2018.26. Review.

PMID:
29749387
14.

Azole-Resistance in Aspergillus terreus and Related Species: An Emerging Problem or a Rare Phenomenon?

Zoran T, Sartori B, Sappl L, Aigner M, Sánchez-Reus F, Rezusta A, Chowdhary A, Taj-Aldeen SJ, Arendrup MC, Oliveri S, Kontoyiannis DP, Alastruey-Izquierdo A, Lagrou K, Cascio GL, Meis JF, Buzina W, Farina C, Drogari-Apiranthitou M, Grancini A, Tortorano AM, Willinger B, Hamprecht A, Johnson E, Klingspor L, Arsic-Arsenijevic V, Cornely OA, Meletiadis J, Prammer W, Tullio V, Vehreschild JJ, Trovato L, Lewis RE, Segal E, Rath PM, Hamal P, Rodriguez-Iglesias M, Roilides E, Arikan-Akdagli S, Chakrabarti A, Colombo AL, Fernández MS, Martin-Gomez MT, Badali H, Petrikkos G, Klimko N, Heimann SM, Uzun O, Roudbary M, de la Fuente S, Houbraken J, Risslegger B, Lass-Flörl C, Lackner M.

Front Microbiol. 2018 Mar 28;9:516. doi: 10.3389/fmicb.2018.00516. eCollection 2018.

15.

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.

Ullmann AJ, Aguado JM, Arikan-Akdagli S, Denning DW, Groll AH, Lagrou K, Lass-Flörl C, Lewis RE, Munoz P, Verweij PE, Warris A, Ader F, Akova M, Arendrup MC, Barnes RA, Beigelman-Aubry C, Blot S, Bouza E, Brüggemann RJM, Buchheidt D, Cadranel J, Castagnola E, Chakrabarti A, Cuenca-Estrella M, Dimopoulos G, Fortun J, Gangneux JP, Garbino J, Heinz WJ, Herbrecht R, Heussel CP, Kibbler CC, Klimko N, Kullberg BJ, Lange C, Lehrnbecher T, Löffler J, Lortholary O, Maertens J, Marchetti O, Meis JF, Pagano L, Ribaud P, Richardson M, Roilides E, Ruhnke M, Sanguinetti M, Sheppard DC, Sinkó J, Skiada A, Vehreschild MJGT, Viscoli C, Cornely OA.

Clin Microbiol Infect. 2018 May;24 Suppl 1:e1-e38. doi: 10.1016/j.cmi.2018.01.002. Epub 2018 Mar 12.

PMID:
29544767
16.

Multicentre determination of rezafungin (CD101) susceptibility of Candida species by the EUCAST method.

Arendrup MC, Meletiadis J, Zaragoza O, Jørgensen KM, Marcos-Zambrano LJ, Kanioura L, Cuenca-Estrella M, Mouton JW, Guinea J.

Clin Microbiol Infect. 2018 Nov;24(11):1200-1204. doi: 10.1016/j.cmi.2018.02.021. Epub 2018 Mar 2.

PMID:
29505881
17.

Polyphasic data support the splitting of Aspergillus candidus into two species; proposal of Aspergillus dobrogensis sp. nov.

Hubka V, Nováková A, Jurjević Ž, Sklenář F, Frisvad JC, Houbraken J, Arendrup MC, Jørgensen KM, Siqueira JPZ, Gené J, Kolařík M.

Int J Syst Evol Microbiol. 2018 Apr;68(4):995-1011. doi: 10.1099/ijsem.0.002583. Epub 2018 Feb 15.

PMID:
29458472
18.

Recurrent terbinafine resistant Trichophyton rubrum infection in a child with congenital ichthyosis.

Schøsler L, Andersen LK, Arendrup MC, Sommerlund M.

Pediatr Dermatol. 2018 Mar;35(2):259-260. doi: 10.1111/pde.13411. Epub 2018 Jan 16.

PMID:
29341312
19.

Update from a 12-Year Nationwide Fungemia Surveillance: Increasing Intrinsic and Acquired Resistance Causes Concern.

Astvad KMT, Johansen HK, Røder BL, Rosenvinge FS, Knudsen JD, Lemming L, Schønheyder HC, Hare RK, Kristensen L, Nielsen L, Gertsen JB, Dzajic E, Pedersen M, Østergård C, Olesen B, Søndergaard TS, Arendrup MC.

J Clin Microbiol. 2018 Mar 26;56(4). pii: e01564-17. doi: 10.1128/JCM.01564-17. Print 2018 Apr.

20.

Emergence of Aspergillus fumigatus azole resistance in azole-naïve patients with chronic obstructive pulmonary disease and their homes.

Dauchy C, Bautin N, Nseir S, Reboux G, Wintjens R, Le Rouzic O, Sendid B, Viscogliosi E, Le Pape P, Arendrup MC, Gosset P, Fry S, Fréalle E.

Indoor Air. 2018 Mar;28(2):298-306. doi: 10.1111/ina.12436. Epub 2017 Nov 20.

PMID:
29082624
21.

Multicentre validation of 4-well azole agar plates as a screening method for detection of clinically relevant azole-resistant Aspergillus fumigatus.

Arendrup MC, Verweij PE, Mouton JW, Lagrou K, Meletiadis J.

J Antimicrob Chemother. 2017 Dec 1;72(12):3325-3333. doi: 10.1093/jac/dkx319.

PMID:
29029256
22.

Multidrug-Resistant Candida: Epidemiology, Molecular Mechanisms, and Treatment.

Arendrup MC, Patterson TF.

J Infect Dis. 2017 Aug 15;216(suppl_3):S445-S451. doi: 10.1093/infdis/jix131. Review.

PMID:
28911043
23.

Fluconazole Pharmacokinetics in Galleria mellonella Larvae and Performance Evaluation of a Bioassay Compared to Liquid Chromatography-Tandem Mass Spectrometry for Hemolymph Specimens.

Astvad KMT, Meletiadis J, Whalley S, Arendrup MC.

Antimicrob Agents Chemother. 2017 Sep 22;61(10). pii: e00895-17. doi: 10.1128/AAC.00895-17. Print 2017 Oct.

24.

Molecular basis of antifungal drug resistance in yeasts.

Morio F, Jensen RH, Le Pape P, Arendrup MC.

Int J Antimicrob Agents. 2017 Nov;50(5):599-606. doi: 10.1016/j.ijantimicag.2017.05.012. Epub 2017 Jun 29. Review.

PMID:
28669835
25.

Implementation of Isavuconazole in a Fluorescence-Based High-Performance Liquid Chromatography Kit Allowing Simultaneous Detection of All Four Currently Licensed Mold-Active Triazoles.

Jørgensen R, Andersen SR, Astvad KMT, Arendrup MC.

mSphere. 2017 May 10;2(3). pii: e00098-17. doi: 10.1128/mSphere.00098-17. eCollection 2017 May-Jun.

26.

Comparison of EUCAST and CLSI Reference Microdilution MICs of Eight Antifungal Compounds for Candida auris and Associated Tentative Epidemiological Cutoff Values.

Arendrup MC, Prakash A, Meletiadis J, Sharma C, Chowdhary A.

Antimicrob Agents Chemother. 2017 May 24;61(6). pii: e00485-17. doi: 10.1128/AAC.00485-17. Print 2017 Jun.

27.

A prospective international Aspergillus terreus survey: an EFISG, ISHAM and ECMM joint study.

Risslegger B, Zoran T, Lackner M, Aigner M, Sánchez-Reus F, Rezusta A, Chowdhary A, Taj-Aldeen SJ, Arendrup MC, Oliveri S, Kontoyiannis DP, Alastruey-Izquierdo A, Lagrou K, Lo Cascio G, Meis JF, Buzina W, Farina C, Drogari-Apiranthitou M, Grancini A, Tortorano AM, Willinger B, Hamprecht A, Johnson E, Klingspor L, Arsic-Arsenijevic V, Cornely OA, Meletiadis J, Prammer W, Tullio V, Vehreschild JJ, Trovato L, Lewis RE, Segal E, Rath PM, Hamal P, Rodriguez-Iglesias M, Roilides E, Arikan-Akdagli S, Chakrabarti A, Colombo AL, Fernández MS, Martin-Gomez MT, Badali H, Petrikkos G, Klimko N, Heimann SM, Houbraken J, Uzun O, Edlinger M, Fuente S, Lass-Flörl C.

Clin Microbiol Infect. 2017 Oct;23(10):776.e1-776.e5. doi: 10.1016/j.cmi.2017.04.012. Epub 2017 Apr 13.

28.

Evaluation of the in vitro activity of isavuconazole and comparator voriconazole against 2635 contemporary clinical Candida and Aspergillus isolates.

Astvad KMT, Hare RK, Arendrup MC.

Clin Microbiol Infect. 2017 Nov;23(11):882-887. doi: 10.1016/j.cmi.2017.03.023. Epub 2017 Apr 1.

29.

Detection of Polish clinical Aspergillus fumigatus isolates resistant to triazoles.

Nawrot U, Kurzyk E, Arendrup MC, Mroczynska M, Wlodarczyk K, Sulik-Tyszka B, Wróblewska M, Ussowicz M, Zdziarski P, Niewinska K, Brillowska-Dabrowska A.

Med Mycol. 2018 Jan 1;56(1):121-124. doi: 10.1093/mmy/myx012.

PMID:
28340159
30.

Successful Treatment of Rhino-Orbital-Cerebral Mucormycosis in a Child With Leukemia.

Jensen TSR, Arendrup MC, von Buchvald C, Frandsen TL, Juhler M, Nygaard U.

J Pediatr Hematol Oncol. 2017 May;39(4):e211-e215. doi: 10.1097/MPH.0000000000000701.

PMID:
27841827
31.

Evaluation of MIC Strip Isavuconazole Test for Susceptibility Testing of Wild-Type and Non-Wild-Type Aspergillus fumigatus Isolates.

Arendrup MC, Verweij P, Nielsen HV.

Antimicrob Agents Chemother. 2016 Dec 27;61(1). pii: e01659-16. doi: 10.1128/AAC.01659-16. Print 2017 Jan.

32.

Spectrophotometric reading of EUCAST antifungal susceptibility testing of Aspergillus fumigatus.

Meletiadis J, Leth Mortensen K, Verweij PE, Mouton JW, Arendrup MC.

Clin Microbiol Infect. 2017 Feb;23(2):98-103. doi: 10.1016/j.cmi.2016.10.017. Epub 2016 Oct 25.

33.

Differences in epidemiology of candidaemia in the Nordic countries - what is to blame?

Hesstvedt L, Arendrup MC, Poikonen E, Klingpor L, Friman V, Nordøy I; Swedish fungal Surveillance Group Collaborators (16).

Mycoses. 2017 Jan;60(1):11-19. doi: 10.1111/myc.12535. Epub 2016 Jul 28.

PMID:
27464892
34.

How to Optimize the Use of Blood Cultures for the Diagnosis of Bloodstream Infections? A State-of-the Art.

Lamy B, Dargère S, Arendrup MC, Parienti JJ, Tattevin P.

Front Microbiol. 2016 May 12;7:697. doi: 10.3389/fmicb.2016.00697. eCollection 2016. Review.

35.

Darier Disease Complicated by Terbinafine-resistant Trichophyton rubrum: A Case Report.

Digby SS, Hald M, Arendrup MC, Hjort SV, Kofoed K.

Acta Derm Venereol. 2017 Jan 4;97(1):139-140. doi: 10.2340/00015555-2455. No abstract available.

36.

Azole-resistant Aspergillus fumigatus in Denmark: a laboratory-based study on resistance mechanisms and genotypes.

Jensen RH, Hagen F, Astvad KM, Tyron A, Meis JF, Arendrup MC.

Clin Microbiol Infect. 2016 Jun;22(6):570.e1-9. doi: 10.1016/j.cmi.2016.04.001. Epub 2016 Apr 16.

37.

Molecular epidemiology and in vitro antifungal susceptibility testing of 108 clinical Cryptococcus neoformans sensu lato and Cryptococcus gattii sensu lato isolates from Denmark.

Hagen F, Hare Jensen R, Meis JF, Arendrup MC.

Mycoses. 2016 Sep;59(9):576-84. doi: 10.1111/myc.12507. Epub 2016 Apr 8.

PMID:
27061834
38.

Invasive Candidiasis.

Kullberg BJ, Arendrup MC.

N Engl J Med. 2016 Feb 25;374(8):794-5. doi: 10.1056/NEJMc1514201. No abstract available.

PMID:
26933864
39.

Recurrent prosthetic valve endocarditis caused by Aspergillus delacroxii (formerly Aspergillus nidulans var. echinulatus).

Uhrin GB, Jensen RH, Korup E, Grønlund J, Hjort U, Moser C, Arendrup MC, Schønheyder HC.

Med Mycol Case Rep. 2015 Dec 19;10:21-3. doi: 10.1016/j.mmcr.2015.12.005. eCollection 2015 Dec.

40.

EUCAST technical note on isavuconazole breakpoints for Aspergillus, itraconazole breakpoints for Candida and updates for the antifungal susceptibility testing method documents.

Arendrup MC, Meletiadis J, Mouton JW, Guinea J, Cuenca-Estrella M, Lagrou K, Howard SJ; Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST).

Clin Microbiol Infect. 2016 Jun;22(6):571.e1-4. doi: 10.1016/j.cmi.2016.01.017. Epub 2016 Feb 3.

41.

Posttreatment Antifungal Resistance among Colonizing Candida Isolates in Candidemia Patients: Results from a Systematic Multicenter Study.

Jensen RH, Johansen HK, Søes LM, Lemming LE, Rosenvinge FS, Nielsen L, Olesen B, Kristensen L, Dzajic E, Astvad KM, Arendrup MC.

Antimicrob Agents Chemother. 2015 Dec 28;60(3):1500-8. doi: 10.1128/AAC.01763-15.

42.

Azole Resistance of Aspergillus fumigatus in Immunocompromised Patients with Invasive Aspergillosis.

van der Linden JW, Arendrup MC, Melchers WJ, Verweij PE.

Emerg Infect Dis. 2016 Jan;22(1):158-9. doi: 10.3201/eid2201.151308. No abstract available.

43.

In Vitro Activity of ASP2397 against Aspergillus Isolates with or without Acquired Azole Resistance Mechanisms.

Arendrup MC, Jensen RH, Cuenca-Estrella M.

Antimicrob Agents Chemother. 2015 Nov 9;60(1):532-6. doi: 10.1128/AAC.02336-15. Print 2016 Jan.

44.

The burden of fungal disease in Denmark.

Mortensen KL, Denning DW, Arendrup MC.

Mycoses. 2015 Oct;58 Suppl 5:15-21. doi: 10.1111/myc.12383.

PMID:
26449502
45.

Invasive Candidiasis.

Kullberg BJ, Arendrup MC.

N Engl J Med. 2015 Oct 8;373(15):1445-56. doi: 10.1056/NEJMra1315399. Review. No abstract available.

PMID:
26444731
46.

In Vitro Activity of Isavuconazole and Comparators against Clinical Isolates of the Mucorales Order.

Arendrup MC, Jensen RH, Meletiadis J.

Antimicrob Agents Chemother. 2015 Dec;59(12):7735-42. doi: 10.1128/AAC.01919-15. Epub 2015 Oct 5.

47.

[Unexpected bronchoscopic findings in sarcoidosis].

Gottlieb M, Perch M, Santoni-Rugiu E, Arendrup MC, Bjarnason NH.

Ugeskr Laeger. 2015 Aug 17;177(34):1630. Danish. No abstract available.

PMID:
26320587
48.

International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus.

Verweij PE, Ananda-Rajah M, Andes D, Arendrup MC, Brüggemann RJ, Chowdhary A, Cornely OA, Denning DW, Groll AH, Izumikawa K, Kullberg BJ, Lagrou K, Maertens J, Meis JF, Newton P, Page I, Seyedmousavi S, Sheppard DC, Viscoli C, Warris A, Donnelly JP.

Drug Resist Updat. 2015 Jul-Aug;21-22:30-40. doi: 10.1016/j.drup.2015.08.001. Epub 2015 Aug 7.

49.

Discovery of a sexual stage in Trichophyton onychocola, a presumed geophilic dermatophyte isolated from toenails of patients with a history of T. rubrum onychomycosis.

Hubka V, Nissen CV, Jensen RH, Arendrup MC, Cmokova A, Kubatova A, Skorepova M, Kolarik M.

Med Mycol. 2015 Nov;53(8):798-809. doi: 10.1093/mmy/myv044. Epub 2015 Jun 30.

PMID:
26129891
50.

Stepwise emergence of azole, echinocandin and amphotericin B multidrug resistance in vivo in Candida albicans orchestrated by multiple genetic alterations.

Jensen RH, Astvad KM, Silva LV, Sanglard D, Jørgensen R, Nielsen KF, Mathiasen EG, Doroudian G, Perlin DS, Arendrup MC.

J Antimicrob Chemother. 2015 Sep;70(9):2551-5. doi: 10.1093/jac/dkv140. Epub 2015 May 27.

Supplemental Content

Loading ...
Support Center